PT1084261E - Vacina para o virus da encefalite equina venezuelana recombinante - Google Patents

Vacina para o virus da encefalite equina venezuelana recombinante

Info

Publication number
PT1084261E
PT1084261E PT99920967T PT99920967T PT1084261E PT 1084261 E PT1084261 E PT 1084261E PT 99920967 T PT99920967 T PT 99920967T PT 99920967 T PT99920967 T PT 99920967T PT 1084261 E PT1084261 E PT 1084261E
Authority
PT
Portugal
Prior art keywords
encephalite
virus
venezuelan horse
recombinant
recombinant venezuelan
Prior art date
Application number
PT99920967T
Other languages
English (en)
Inventor
Alice Marie Bennett
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Publication of PT1084261E publication Critical patent/PT1084261E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99920967T 1998-05-29 1999-05-05 Vacina para o virus da encefalite equina venezuelana recombinante PT1084261E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9811433A GB2337755B (en) 1998-05-29 1998-05-29 Virus vaccine

Publications (1)

Publication Number Publication Date
PT1084261E true PT1084261E (pt) 2005-01-31

Family

ID=10832820

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99920967T PT1084261E (pt) 1998-05-29 1999-05-05 Vacina para o virus da encefalite equina venezuelana recombinante

Country Status (14)

Country Link
US (2) US6936257B1 (pt)
EP (1) EP1084261B8 (pt)
AR (1) AR020080A1 (pt)
AT (1) ATE275631T1 (pt)
AU (1) AU3834999A (pt)
BR (1) BR9910814A (pt)
CA (1) CA2329133C (pt)
DE (1) DE69920011T2 (pt)
DK (1) DK1084261T3 (pt)
ES (1) ES2224655T3 (pt)
GB (1) GB2337755B (pt)
MX (1) MXPA00011708A (pt)
PT (1) PT1084261E (pt)
WO (1) WO1999063098A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
AU1194802A (en) 2000-03-02 2001-12-11 Univ Emory DNA expression vectors and methods of use
ATE445411T1 (de) 2001-03-08 2009-10-15 Us Gov Health & Human Serv Mva-exprimierende modifizierte hiv-envelope-, gag-und pol-gene
EP1528677B1 (en) * 2003-10-30 2006-05-10 Agilent Technologies, Inc. Film acoustically-coupled transformer with two reverse c-axis piezoelectric elements
EP2114459B1 (en) * 2007-02-23 2013-09-25 Her Majesty The Queen, In Right Of Canada, As Represented by the Minister of National Defence Recombinant viral vectors for prevention and protection against alphavirus infection
WO2010142017A1 (en) 2009-06-09 2010-12-16 Defyrus, Inc . Administration of interferon for prophylaxis against or treatment of pathogenic infection
JP2014510721A (ja) 2011-02-15 2014-05-01 イミューン デザイン コーポレイション ベクターワクチンによる免疫原特異的免疫応答を強化するための方法
MX350795B (es) 2011-04-08 2017-09-19 Inmune Design Corp Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
WO2013151567A1 (en) * 2012-04-04 2013-10-10 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research Institute Of Infectious Diseases Equine encephalitis virus vaccines and methods of using thereof
PT2850431T (pt) 2012-05-16 2018-07-23 Immune Design Corp Vacinas para hsv-2
RU2673156C2 (ru) * 2012-11-05 2018-11-22 Ридженерон Фармасьютикалз, Инк. Генетически модифицированные не относящиеся к человеческому роду животные и способы их применения
BR112016018521A2 (pt) 2014-02-14 2017-10-17 Immune Design Corp composição, e, kit.
MX2017000630A (es) 2014-07-15 2017-04-27 Immune Design Corp Regimenes de sensibilización-refuerzo con un adyuvante de agonista tlr4 y un vector lentiviral.
WO2017129765A1 (en) 2016-01-29 2017-08-03 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
CA3019199A1 (en) 2016-04-15 2017-10-19 Alpine Immune Sciences, Inc. Icos ligand variant immunomodulatory proteins and uses thereof
MA43552A (fr) 2016-04-15 2018-11-07 Alpine Immune Sciences Inc Protéines immunomodulatrices à variants de cd80 et leurs utilisations
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
CN110088127A (zh) 2016-07-28 2019-08-02 高山免疫科学股份有限公司 Cd155变体免疫调节蛋白及其用途
CN110831963A (zh) 2017-03-16 2020-02-21 高山免疫科学股份有限公司 Pd-l1变体免疫调节蛋白及其用途
EP3596114A2 (en) 2017-03-16 2020-01-22 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
JP2020511144A (ja) 2017-03-16 2020-04-16 アルパイン イミューン サイエンシズ インコーポレイテッド Ｐｄ−ｌ２バリアント免疫調節タンパク質及びその使用
WO2018176103A1 (en) 2017-03-30 2018-10-04 The University Of Queensland "chimeric molecules and uses thereof"
CA3077509A1 (en) 2017-10-10 2019-04-18 Alpine Immune Sciences, Inc. Ctla-4 variant immunomodulatory proteins and uses thereof
AU2018351000B2 (en) 2017-10-18 2023-11-30 Alpine Immune Sciences, Inc. Variant ICOS Ligand immunomodulatory proteins and related compositions and methods
CA3087149A1 (en) 2018-01-03 2019-07-11 Alpine Immune Sciences, Inc. Multi-domain immunomodulatory proteins and methods of use thereof
WO2019241758A1 (en) 2018-06-15 2019-12-19 Alpine Immune Sciences, Inc. Pd-1 variant immunomodulatory proteins and uses thereof
SG11202102644XA (en) 2018-09-19 2021-04-29 Alpine Immune Sciences Inc Methods and uses of variant cd80 fusion proteins and related constructs
CA3120868A1 (en) 2018-11-30 2020-06-04 Alpine Immune Sciences, Inc. Cd86 variant immunomodulatory proteins and uses thereof
BR112021020447A2 (pt) 2019-04-17 2022-05-17 Alpine Immune Sciences Inc Métodos e usos de proteínas de fusão de ligante icos variante (icosl)
AU2021268033A1 (en) 2020-05-08 2022-12-15 Alpine Immune Sciences, Inc. APRIL and BAFF inhibitory immunomodulatory proteins with and without a T cell inhibitory protein and methods of use thereof
WO2022236335A1 (en) 2021-05-07 2022-11-10 Alpine Immune Sciences, Inc. Methods of dosing and treatment with a taci-fc fusion immunomodulatory protein
WO2023172883A1 (en) 2022-03-07 2023-09-14 Alpine Immune Sciences, Inc. Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
WO2024077018A2 (en) 2022-10-04 2024-04-11 Alpine Immune Sciences, Inc. Methods and uses of taci-fc fusion immunomodulatory protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185440A (en) * 1989-06-20 1993-02-09 North Carolina State University cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof
US5505947A (en) * 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
US6261570B1 (en) * 1997-05-20 2001-07-17 The United States Of America As Represented By The Secretary Of The Army Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine

Also Published As

Publication number Publication date
ES2224655T3 (es) 2005-03-01
GB2337755B (en) 2003-10-29
USRE41745E1 (en) 2010-09-21
ATE275631T1 (de) 2004-09-15
AR020080A1 (es) 2002-04-10
US6936257B1 (en) 2005-08-30
CA2329133C (en) 2011-07-12
EP1084261B8 (en) 2004-12-15
CA2329133A1 (en) 1999-12-09
WO1999063098A1 (en) 1999-12-09
DK1084261T3 (da) 2005-01-17
EP1084261B1 (en) 2004-09-08
MXPA00011708A (es) 2005-10-13
AU3834999A (en) 1999-12-20
EP1084261A1 (en) 2001-03-21
GB2337755A (en) 1999-12-01
BR9910814A (pt) 2001-02-13
GB9811433D0 (en) 1998-07-22
DE69920011D1 (de) 2004-10-14
DE69920011T2 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
PT1084261E (pt) Vacina para o virus da encefalite equina venezuelana recombinante
DE69936170D1 (de) Beatmungsgerät
IT1308659B1 (it) Reticolante per fotoresist e composizione fotoresist comprendente lostesso.
NL1010890C2 (nl) Stabilisatormengsel.
DE69940046D1 (de) Schwimmflosse
NO20004522D0 (no) Kitinase-kitinbindende fragmenter
PT1109526E (pt) Estabilidade melhorada para solucoes injectaveis
DE69918991D1 (de) Thermostabilisierte. segmentierte polyetherester-zusammensetzung
PT9493T (pt) Cabeca para esfregona
IT1308660B1 (it) Reticolante per fotoresist e composizione fotoresist comprendente lostesso.
PT1124567E (pt) Composicoes tamponadas para dialise
DE19982534D2 (de) Spriegelausführung
BR9508281A (pt) Técnica para autenticação
DE29814293U1 (de) Entstaubungsanlage
ES1035133Y (es) Componente para encofrados.
ES1042596Y (es) Disposicion perfeccionada para alcorques.
DE69907428D1 (de) Katalysatorzusammensetzung
ES1038871Y (es) Soporte para banderas.
DE29723222U1 (de) Beatmungsgerät
KR980004330U (ko) 벤틸레이터
DE29800057U1 (de) Projektordner
ES1036929Y (es) Bandera para espectaculos.
ES1039814Y (es) Ajedrez para invidentes.
ES1039750Y (es) Componente para encofrados.
ES1045281Y (es) Losa para cubiertas perfeccionada.